Global Fecal Occult Blood (FOBT) Rapid Diagnostic Test Market Growth (Status and Outlook) 2025-2031

According to this study, the global Fecal Occult Blood (FOBT) Rapid Diagnostic Test market size will reach US$ million by 2031.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

LPI (LP Information)' newest research report, the “Fecal Occult Blood (FOBT) Rapid Diagnostic Test Industry Forecast” looks at past sales and reviews total world Fecal Occult Blood (FOBT) Rapid Diagnostic Test sales in 2024, providing a comprehensive analysis by region and market sector of projected Fecal Occult Blood (FOBT) Rapid Diagnostic Test sales for 2025 through 2031. With Fecal Occult Blood (FOBT) Rapid Diagnostic Test sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fecal Occult Blood (FOBT) Rapid Diagnostic Test industry.

This Insight Report provides a comprehensive analysis of the global Fecal Occult Blood (FOBT) Rapid Diagnostic Test landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Fecal Occult Blood (FOBT) Rapid Diagnostic Test portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Fecal Occult Blood (FOBT) Rapid Diagnostic Test market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fecal Occult Blood (FOBT) Rapid Diagnostic Test and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fecal Occult Blood (FOBT) Rapid Diagnostic Test.

This report presents a comprehensive overview, market shares, and growth opportunities of Fecal Occult Blood (FOBT) Rapid Diagnostic Test market by product type, application, key players and key regions and countries.

Segmentation by Type:
Immunochemical Fecal Occult Blood Test (iFOBT or FIT)
Guaiac Fecal Occult Blood Test (gFOBT)

Segmentation by Application:
Hospital
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Alfa Scientific Designs
Humasis
Diagnosis SA
Apacor Ltd.
Labtest Diagnostica
Firstep Bioresearch, Inc.
LifeSign PBM
Immunostics Inc.
Quidel
RTA Laboratories
Teco Diagnostics
Ameritek, Inc.
Aidian Oy
EKF Diagnostics
BIOMERICA
VIDIA
MH Medical
NanoEntek

Please note: The report will take approximately 2 business days to prepare and deliver. Show more